Ipilimumab

  • Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
    Margaret Callahan, Asim Amin, Frederic J Kaye, Michael A Morse, Matthew H Taylor, Katriina J Peltola, Padmanee Sharma, Eileen M O'Reilly, Stephanie Meadows Shropshire, Shaun O'Brien, Marina Tschaika, Dung T Le
  • Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial
    Renske M T ten Ham, Maartje W Rohaan, Inge Jedema, Rob Kessels, Wim Stegeman, Walter Scheepmaker, Bastiaan Nuijen, Cynthia Nijenhuis, Melanie Lindenberg, Troels Holz Borch, Tine Monberg, Marco Donia, Inge Marie Svane, Wim van Harten, John Haanen, Valesca P Retel
  • Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity
    Xizi Hu, Shoiab M Bukhari, Carly Tymm, Kieran Adam, Shalom Lerrer, Brian S Henick, Robert J Winchester, Adam Mor
  • Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
    Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Claire Quaghebeur, Bjørnar Gilje, Beate Boge, Andrea Gombos, Ragnhild Sørum Falk, Randi R. Mathiesen, Lars Julsrud, Øystein Garred, Hege G. Russnes, Ragnhild Reehorst Lereim, Sudhir Kumar Chauhan, Ole Christian Lingjærde, Claire Dunn, Bjørn Naume, Jon Amund Kyte
  • Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series
    Catriona Harvey, Kazi J Nahar, Janet McKeown, Serigne N Lo, Sheima Farag, Nadia Yousaf, Kate Young, Liselotte Tas, Aafke Meerveld-Eggink, Christian Blank, Austin Thomas, Jennifer McQuade, Bastian Schilling, Douglas B Johnson, Roberto Martín Huertas, Ana Arance, Joanna Lee, Lisa Zimmer, Georgina V Long, Matteo S Carlino, Yinghong Wang, Alexander Maxwell Menzies
  • Evaluation of tissue- and plasma-derived tumor mutational burden (TMB) and genomic alterations of interest in CheckMate 848, a study of nivolumab combined with ipilimumab and nivolumab alone in patients with advanced or metastatic solid tumors with high TMB
    Jie He, Natallia Kalinava, Parul Doshi, Dean C Pavlick, Lee A Albacker, Ericka M Ebot, Hanna Tukachinsky, James Pratt, Gina Fusaro, Geoffrey R Oxnard, George Green, David Fabrizio, Jonathan Baden
  • Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
    Jennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, Ayesha Ali, Voichita Bar Ad, Rita Axelrod, Emily Lorber, Joseph Curry, David M Cognetti, Adam J Luginbuhl, Madalina Tuluc, Scott Keith, Mỹ G Mahoney, Athanassios Argiris
  • XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer
    Kurt A Jenkins, Miso Park, Magali Pederzoli-Ribeil, Ugur Eskiocak, Parker Johnson, Wilson Guzman, Megan McLaughlin, Deborah Moore-Lai, Caitlin O’Toole, Zhen Liu, Benjamin Nicholson, Veronica Flesch, Huawei Qiu, Tim Clackson, Ronan C O’Hagan, Ulrich Rodeck, Margaret Karow, Jennifer O’Neil, John C Williams
  • Management of immune-related cutaneous adverse events with dupilumab
    Alyce Mei-Shiuan Kuo, Stephanie Gu, Joseph Stoll, Andrea P Moy, Stephen W Dusza, Allison Gordon, Elena C Haliasos, Yelena Janjigian, Lukas Kraehenbuehl, Elizabeth A Quigley, Paul Chapman, Mario E Lacouture, Alina Markova
  • Abstracts from the 4th ImmunoTherapy of Cancer Conference
    J. Ženka, V. Caisová, O. Uher, P. Nedbalová, K. Kvardová, K. Masáková, G. Krejčová, L. Paďouková, I. Jochmanová, K. I. Wolf, J. Chmelař, J. Kopecký, L. Loumagne, J. Mestadier, S. D’agostino, A. Rohaut, Y. Ruffin, V. Croize, O. Lemaître, S. S. Sidhu, S. Althammer, K. Steele, M. Rebelatto, T. Tan, T. Wiestler, A. Spitzmueller, R. Korn, G. Schmidt, B. Higgs, X. Li, L. Shi, X. Jin, K. Ranade, S. Koeck, A. Amann, G. Gamerith, M. Zwierzina, E. Lorenz, H. Zwierzina, J. Kern, M. Riva, T. Baert, A. Coosemans, R. Giovannoni, E. Radaelli, W. Gsell, U. Himmelreich, M. Van Ranst, F. Xing, W. Qian, C. Dong, X. Xu, S. Guo, Q. Shi, D. Quandt, B. Seliger, C. Plett, D. C. Amberger, A. Rabe, D. Deen, Z. Stankova, A. Hirn, Y. Vokac, J. Werner, D. Krämer, A. Rank, C. Schmid, H. Schmetzer, M. Guerin, J. M. Weiss, F. Regnier, G. Renault, L. Vimeux, E. Peranzoni, V. Feuillet, M. Thoreau, T. Guilbert, A. Trautmann, N. Bercovici, D. C. Amberger, F. Doraneh-Gard, C. L. Boeck, C. Plett, C. Gunsilius, C. Kugler, J. Werner, J. Schmohl, D. Kraemer, B. Ismann, A. Rank, C. Schmid, H. M. Schmetzer, A. Markota, C. Ochs, P. May, A. Gottschlich, J. Suárez Gosálvez, C. Karches, D. Wenk, S. Endres, S. Kobold, T. Hilmenyuk, R. Klar, F. Jaschinski, G. Gamerith, F. Augustin, E. Lorenz, C. Manzl, E. Hoflehner, P. Moser, B. Zelger, S. Köck, A. Amann, J. Kern, G. Schäfer, D. Öfner, H. Maier, H. Zwierzina, S. Sopper, H. Prado-Garcia, S. Romero-Garcia, R. Sandoval-Martínez, A. Puerto-Aquino, J. Lopez-Gonzalez, U. Rumbo-Nava, R. Klar, T. Hilmenyuk, F. Jaschinski, A. Coosemans, T. Baert, A. Van Hoylandt, P. Busschaert, I. Vergote, T. Baert, A. Van Hoylandt, P. Busschaert, I. Vergote, A. Coosemans, J. Laengle, K. Pilatova, E. Budinska, B. Bencsikova, R. Sefr, R. Nenutil, V. Brychtova, L. Fedorova, B. Hanakova, L. Zdrazilova-Dubska, Chris Allen, Yuan-Chieh Ku, Warren Tom, Yongming Sun, Alex Pankov, Tim Looney, Fiona Hyland, Janice Au-Young, Ann Mongan, A. Becker, J. B. L. Tan, A. Chen, K. Lawson, E. Lindsey, J. P. Powers, M. Walters, U. Schindler, S. Young, J. C. Jaen, S. Yin, Y. Chen, I. Gullo, G. Gonçalves, M. L. Pinto, M. Athelogou, G. Almeida, R. Huss, C. Oliveira, F. Carneiro, C. Merz, J. Sykora, K. Hermann, R. Hussong, D. M. Richards, H. Fricke, O. Hill, C. Gieffers, M. P. Pinho, J. A. M. Barbuto, S. E. McArdle, G. Foulds, J. N. Vadakekolathu, T. M. A. Abdel-Fatah, C. Johnson, S. Hood, P. Moseley, R. C. Rees, S. Y. T. Chan, A. G. Pockley, S. Rutella, C. Geppert, A. Hartmann, K. Senthil Kumar, M. Gokilavani, S. Wang, C. Merz, D. M. Richards, J. Sykora, M. Redondo-Müller, K. Heinonen, V. Marschall, M. Thiemann, H. Fricke, C. Gieffers, O. Hill, L. Zhang, B. Mao, Y. Jin, G. Zhai, Z. Li, Z. Wang, W. Qian, X. An, M. Qiao, J. Zhang, Q. Shi, J. Weber, H. Kluger, R. Halaban, M. Sznol, H. Roder, J. Roder, J. Grigorieva, S. Asmellash, C. Oliveira, K. Meyer, A. Steingrimsson, S. Blackmon, R. Sullivan, C. L. Boeck, D. C. Amberger, F. Doraneh-Gard, W. Sutanto, T. Guenther, J. Schmohl, F. Schuster, H. Salih, F. Babor, A. Borkhardt, H. Schmetzer, Y. Kim, I. Oh, C. Park, S. Ahn, K. Na, S. Song, Y. Choi, L. Fedorova, A. Poprach, R. Lakomy, I. Selingerova, R. Demlova, K. Pilatova, S. Kozakova, D. Valik, K. Petrakova, R. Vyzula, L. Zdrazilova-Dubska, D. Aguilar-Cazares, M. Galicia-Velasco, C. Camacho-Mendoza, L. Islas-Vazquez, R. Chavez-Dominguez, C. Gonzalez-Gonzalez, H. Prado-Garcia, J. S. Lopez-Gonzalez, S. Yang, K. D. Moynihan, M. Noh, A. Bekdemir, F. Stellacci, D. J. Irvine, B. Volz, K. Kapp, D. Oswald, B. Wittig, M. Schmidt, R. Chavez-Dominguez, D. Aguilar-Cazares, H. Prado-Garcia, L. Islas-Vazquez, J. S. Lopez-Gonzalez, R. Kleef, A. Bohdjalian, D. McKee, R. W. Moss, Mesha Saeed, Sara Zalba, Reno Debets, Timo L. M. ten Hagen, S. Javed, J. Becher, F. Koch-Nolte, F. Haag, E. M. Gordon, K. K. Sankhala, N. Stumpf, W. Tseng, S. P. Chawla, N. González Suárez, G. Bergado Báez, M. Cruz Rodríguez, A. Gutierrez Pérez, L. Chao García, D. Hernández Fernández, J. Raymond Pous, B. Sánchez Ramírez, C. Jacoberger-Foissac, H. Saliba, C. Seguin, A. Brion, B. Frisch, S. Fournel, B. Heurtault, T. Otterhaug, M. Håkerud, A. Nedberg, V. Edwards, P. Selbo, A. Høgset, T. Jaitly, J. Dörrie, N. Schaft, S. Gross, B. Schuler-Thurner, S. Gupta, L. Taher, G. Schuler, J. Vera, F. Rataj, F. Kraus, S. Grassmann, M. Chaloupka, S. Lesch, C. Heise, S. Endres, S. Kobold, B. M. Loureiro Cadilha, K. Dorman, C. Heise, F. Rataj, S. Endres, S. Kobold

Pages